Udik Pharmaceuticals Private Limited
About Udik Pharmaceuticals Private Limited
Data last updated:
Udik Pharmaceuticals Private Limited is a private limited company based in Bareilly, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 September 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24232UP1998PTC023882. Its GSTIN is 09AAACU6812F1ZE (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.2 Lakh. It is led by directors including Rakesh Behari Gupta and Sarthak Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 95 Prabhat Nagar, Bareilly, Uttar Pradesh, India – 243001.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.86 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹5.95 Lakh (net margin 2.1%) and EBITDA of ₹8.36 Lakh (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 1% over five years.
The company has about 21 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Udik Pharmaceuticals Private Limited's registered office is in Bareilly, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address95 Prabhat Nagar, Bareilly, Uttar Pradesh, India – 243001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Udik Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Udik Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Udik Pharmaceuticals Private Limited, buy the company report.
Financials of Udik Pharmaceuticals Private Limited
FY 2025 filings availableUdik Pharmaceuticals Private Limited reported revenue of ₹2.86 Cr (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.36 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.95 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | ||||
| Net Profit Margin | 2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Udik Pharmaceuticals Private Limited, buy the company report.
Board of directors of Udik Pharmaceuticals Private Limited
Udik Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakesh Behari Gupta Also directs: Unix Biotech Limited, Healthturf Services Private Limited | Director | 25 Sep 1998 | 28 Years 0 Months | Current |
| Sarthak Gupta | Director | 05 Dec 2023 | 2 Years 10 Months | Current |
| Asha Gupta Also directs: Unix Biotech Limited | Director | 15 Dec 2002 | 23 Years 10 Months | Current |
Peer comparison
Udik Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vizyon Pharmaceuticals Private Limited | ₹2.87 Cr (FY 2025) | 29.0% | Nagpur, Maharashtra, India | |||
| Madbris Life Sciences Private Limited | ₹2.87 Cr (FY 2025) | 12.0% | Indore, Madhya Pradesh, India | |||
| Notion Pharma Private Limited | ₹2.86 Cr (FY 2024) | 410.0% | Indore, Madhya Pradesh, India | |||
| Udik Pharmaceuticals Private Limitedthis company | ₹2.86 Cr (FY 2025) | ₹5.95 Lakh | 2.1% | -2.0% | 21 | Bareilly, Uttar Pradesh, India |
| Moral Nutraceuticals Private Limited | ₹2.86 Cr (FY 2025) | 6.0% | Ahmedabad, Gujarat, India | |||
| Elipse Labs Marketing Private Limited | ₹2.86 Cr (FY 2025) | 0.0% | Thrissur, Kerala, India |
To see the full peer comparison of Udik Pharmaceuticals Private Limited, buy the company report.
Auditor
Udik Pharmaceuticals Private Limited is audited by AGARWAL GUPTA & KOHLI for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGARWAL GUPTA & KOHLI | FY 2020 | 009846C |
Shareholding
The shareholding of Udik Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Udik Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Sep 2006 | 10016777 | The Nainital Bank Limited | ₹10 Lakh | Open |
To see the full charge records of Udik Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Udik Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Udik Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Udik Pharmaceuticals Private Limited has a workforce of 21 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
GST
Udik Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAACU6812F1ZE | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Udik Pharmaceuticals Private Limited, buy the company report.
Recent activity
Udik Pharmaceuticals Private Limited has 5 board changes on record since 1998: 3 appointments and 2 cessations. The latest: Sarthak Gupta ceased to be Additional Director on 29 Sep 2024.
Frequently asked questions
Udik Pharmaceuticals is an active private limited company based in Bareilly, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 September 1998 (28+ years old) and is registered under CIN U24232UP1998PTC023882.
Udik Pharmaceuticals has 3 current directors:
- Rakesh Behari Gupta - Director
- Sarthak Gupta - Director
- Asha Gupta - Director
The latest financial statements of Udik Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Udik Pharmaceuticals is 09AAACU6812F1ZE, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Udik Pharmaceuticals is U24232UP1998PTC023882. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Udik Pharmaceuticals was incorporated on 25 September 1998, making it 28+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Udik Pharmaceuticals by revenue are Vizyon Pharmaceuticals Private Limited, Madbris Life Sciences Private Limited, Notion Pharma Private Limited, Moral Nutraceuticals Private Limited, Elipse Labs Marketing Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Sarthak Gupta ceased to be Additional Director on 29 Sep 2024. Vandana Gupta ceased to be Director on 09 Mar 2024. Sarthak Gupta was appointed as Director on 05 Dec 2023. Udik Pharmaceuticals has 5 board changes on record in total.
The registered office of Udik Pharmaceuticals is at 95 Prabhat Nagar, Bareilly, Uttar Pradesh, India – 243001.
Udik Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Udik Pharmaceuticals has open charges of ₹10 Lakh and no satisfied charges on record as per latest MCA filings.